Imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes

摘要

The invention relates to the use of compounds of formula (I) or (II)
in the treatment of mammalian target of VEGF-driven angiogenic diseases, methods of use of said compounds in the treatment of said diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising said compounds for the treatment of said diseases and said compounds for use in the treatment of said diseases.